US stocks trimmed losses on Thursday after President Trump's sweeping tariffs hit dozens of US trade partners after his self-imposed deadline for countries to strike deals expired. Meanwhile, Trump also previewed coming chip tariffs, suggesting a carveout could benefit Big Tech companies.
The tech-heavy Nasdaq Composite (^IXIC) rose nearly 0.4% to close at a fresh record, while the S&P 500 (^GSPC) ended little changed. The Dow Jones Industrial Average (^DJI) slipped 0.4%.
Stocks trimmed losses after Trump announced Stephen Miran, the current chairman of the Council of Economic Advisors will serve on the Federal Reserve Board of Governors until Jan 31, 2026, following Adriana Kugler's resignation last Friday.
Trump's deadline for trade deals landed at 12:01 a.m. ET on Thursday. Imports from nearly 200 countries now face duties ranging from 10% to 50%, and the overall average effective tariff rate is projected to jump to 18.6%, according to the Yale Budget Lab, the highest since 1933.
Read more: The latest on Trump's tariffs
Meanwhile, Apple (AAPL) shares climbed Thursday as Trump and CEO Tim Cook announced the company would make a $100 billion investment in the US. As part of the deal, Apple will manufacture the cover glasses for iPhones and Apple Watches in Kentucky.
At the same time, Trump's comments that he'd exempt some companies from his plans to place 100% duties on semiconductors gave tech stocks an overall boost for a second consecutive day. Nvidia (NVDA) stock rose around 0.7%.
Stocks pared gains in the early morning session after Bloomberg reported Federal Reserve Governor Christopher Waller is “emerging as a top candidate” to serve as the central bank's next chair. Trump is expected to announce a replacement for departing Fed governor Adriana Kugler in the coming days.
Meanwhile, another wave of earnings flooded in Thursday morning. The reports featured a tariff warning from Toyota (TM), which said in its first quarter results that the impact of US tariffs will be some $9.5 billion. Among other notable corporate giants to report, Eli Lilly's (LLY) disappointing results of its much-awaited oral GLP-1 pill trial sent the stock down 14% despite posting better-than-expected earnings for the second quarter.
Also on Thursday, 1.974 million continuing claims for unemployment benefits were filed, reaching their highest level since November 2021. The state of the labor market is in high focus following a disappointing July jobs report and downbeat revisions to the May and June jobs reports.
LIVE 21 updates